*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p>Semaglutide is a <strong>GLP-1 receptor agonist</strong> synthesized via solid-phase peptide synthesis. Its molecular formula is C<sub>31</sub>H<sub>47</sub>N<sub>9</sub>O<sub>6</sub>, with CAS No. 91046-68-7.</p>
<h3>Application</h3>
<ul>
<li><strong>Pharmaceutical Manufacturing:</strong> Production of injectable solutions for type 2 diabetes management.</li>
<li><strong>Obesity Treatment:</strong> Formulation of weight loss therapies targeting appetite regulation.</li>
<li><strong>Clinical Research:</strong> Usage in metabolic syndrome studies and cardiovascular outcome trials.</li>
</ul>
<h3>Precautions</h3>
<p>Contraindicated in patients with personal or family history of medullary thyroid carcinoma. Store at 2°C to 8°C; protect from light and freezing temperatures to maintain stability.</p>